Hwang-Verslues WW - Search Results

1

HNF4α--role in drug metabolism and potential drug target?

Hwang-Verslues WW, Sladek FM. Hwang-Verslues WW, et al. Curr Opin Pharmacol. 2010 Dec;10(6):698-705. doi: 10.1016/j.coph.2010.08.010. Curr Opin Pharmacol. 2010. PMID: 20833107 Free PMC article. Review.

2

Tumour suppressor p53 down-regulates the expression of the human hepatocyte nuclear factor 4alpha (HNF4alpha) gene.

Maeda Y, Hwang-Verslues WW, Wei G, Fukazawa T, Durbin ML, Owen LB, Liu X, Sladek FM. Maeda Y, et al. Biochem J. 2006 Dec 1;400(2):303-13. doi: 10.1042/BJ20060614. Biochem J. 2006. PMID: 16895524 Free PMC article.

3

Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter.

Hwang-Verslues WW, Sladek FM. Hwang-Verslues WW, et al. Mol Endocrinol. 2008 Jan;22(1):78-90. doi: 10.1210/me.2007-0298. Epub 2007 Sep 20. Mol Endocrinol. 2008. PMID: 17885207 Free PMC article.

4

Integrated approach for the identification of human hepatocyte nuclear factor 4alpha target genes using protein binding microarrays.

Bolotin E, Liao H, Ta TC, Yang C, Hwang-Verslues W, Evans JR, Jiang T, Sladek FM. Bolotin E, et al. Hepatology. 2010 Feb;51(2):642-53. doi: 10.1002/hep.23357. Hepatology. 2010. PMID: 20054869 Free PMC article.

5

Nuclear receptor HNF4α binding sequences are widespread in Alu repeats.

Bolotin E, Chellappa K, Hwang-Verslues W, Schnabl JM, Yang C, Sladek FM. Bolotin E, et al. BMC Genomics. 2011 Nov 15;12:560. doi: 10.1186/1471-2164-12-560. BMC Genomics. 2011. PMID: 22085832 Free PMC article.

6

miR-495 is upregulated by E12/E47 in breast cancer stem cells, and promotes oncogenesis and hypoxia resistance via downregulation of E-cadherin and REDD1.

Hwang-Verslues WW, Chang PH, Wei PC, Yang CY, Huang CK, Kuo WH, Shew JY, Chang KJ, Lee EY, Lee WH. Hwang-Verslues WW, et al. Oncogene. 2011 May 26;30(21):2463-74. doi: 10.1038/onc.2010.618. Epub 2011 Jan 24. Oncogene. 2011. PMID: 21258409

7

Biomarkers to Target Heterogeneous Breast Cancer Stem Cells.

Hwang-Verslues WW, Lee WH, Lee EY. Hwang-Verslues WW, et al. J Mol Biomark Diagn. 2012;Suppl 8:6. doi: 10.4172/2155-9929.S8-006. J Mol Biomark Diagn. 2012. PMID: 24977105 Free PMC article.

8

A Novel Dual HDAC6 and Tubulin Inhibitor, MPT0B451, Displays Anti-tumor Ability in Human Cancer Cells in Vitro and in Vivo.

Wu YW, Hsu KC, Lee HY, Huang TC, Lin TE, Chen YL, Sung TY, Liou JP, Hwang-Verslues WW, Pan SL, HuangFu WC. Wu YW, et al. Among authors: hwang verslues ww. Front Pharmacol. 2018 Mar 13;9:205. doi: 10.3389/fphar.2018.00205. eCollection 2018. Front Pharmacol. 2018. PMID: 29593536 Free PMC article.

9

Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy.

Hwang-Verslues WW, Chang PH, Jeng YM, Kuo WH, Chiang PH, Chang YC, Hsieh TH, Su FY, Lin LC, Abbondante S, Yang CY, Hsu HM, Yu JC, Chang KJ, Shew JY, Lee EY, Lee WH. Hwang-Verslues WW, et al. Proc Natl Acad Sci U S A. 2013 Jul 23;110(30):12331-6. doi: 10.1073/pnas.1222684110. Epub 2013 Jul 8. Proc Natl Acad Sci U S A. 2013. PMID: 23836662 Free PMC article.

10

Targeting IL-17B-IL-17RB signaling with an anti-IL-17RB antibody blocks pancreatic cancer metastasis by silencing multiple chemokines.

Wu HH, Hwang-Verslues WW, Lee WH, Huang CK, Wei PC, Chen CL, Shew JY, Lee EY, Jeng YM, Tien YW, Ma C, Lee WH. Wu HH, et al. J Exp Med. 2015 Mar 9;212(3):333-49. doi: 10.1084/jem.20141702. Epub 2015 Mar 2. J Exp Med. 2015. PMID: 25732306 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22 results

Search Page

Filters